Showing 761-770 of 990 results for "".
- MD360 Introduces Silkro RF Microneedling Platform with Plasmahttps://modernaesthetics.com/news/md360-introduces-silkro-rf-microneedling-platform-with-plasma/2473410/MD360 is rolling out the Silkro RF Microneedling Platform with Plasma. Developed with the South Korean Intelligent Design Team and Research and Developer HIRONIC, this platform includes four handpieces: Silk RF MN, Silkro Plasma, Silkro Smooth, Silkro Precision, and Silkro Gentle.
- CoolSculpting Elite Announces First-Ever CoolMonthhttps://modernaesthetics.com/news/coolsculpting-elite-announces-first-ever-coolmonth/2473386/April 2023 marks the first-ever CoolMonth, according to Allergan Aesthetics, an AbbVie company and the parent company of CoolSculpting Elite. Why April? A survey revealed 85% of people have a season in which they begin to think more about getting rid of stubborn body fat, and for 4
- New Research Reveals Anti-Aging Potential Found in an Invasive Weedhttps://modernaesthetics.com/news/new-research-reveals-anti-aging-potential-found-in-an-invasive-weed/2473385/The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research
- Establishment Labs Surpasses 3 Million Motiva Deviceshttps://modernaesthetics.com/news/establishment-labs-surpasses-3-million-motiva-devices/2473383/Establishment Labs Holdings announced that it has surpassed 3 million Motiva devices in market. The devices have been delivered to plastic and reconstructive surgeons since 2010 and are available in more than 85 countries. “Since its founding, Establishment Labs has been guid
- Aziyo Biologics, Sientra Partner to Distribute SimpliDerm Productshttps://modernaesthetics.com/news/aziyo-biologics-sientra-partner-to-distribute-simpliderm-product-line/2473379/Aziyo Biologics, Inc. and Sientra, Inc. are joining forces to expand the distribution of Aziyo’s SimpliDerm product line. Under the agreement terms, Aziyo will grant Sientra certain non-exclusive rights in the United States to market, sell, and distribute SimpliDerm fo
- Winners of the BTL Cares Scholarship Program Announcedhttps://modernaesthetics.com/news/winners-of-the-btl-cares-scholarship-program-announced/2473376/BTL Industries, along with professional golfer Michelle Wie West, have announced the winners of the second annual BTL Cares Scholar Draft. The program awards five student-athletes a $15,000 grant for tuition and college fees. The Scholar Draft aims to empow
- Vaginal Laser Treatment Shows Promise in Treating OABhttps://modernaesthetics.com/news/vaginal-laser-treatment-shows-promise-in-treating-oab/2473368/Vaginal laser surgery may be effective in treating overactive bladder syndrome (OAB), according to a study in Menopause. Erbium: Yttrium-Aluminum-Garnet (Erbium YAG) vaginal laser treatment is already used to treat various symptoms of the genitourinary syndrome of menopause, vagina
- iCRYO to Bring BTL Devices to Franchiseshttps://modernaesthetics.com/news/icryo-to-bring-btl-devices-to-franchises/2473353/iCRYO is partnering with BTL Industries to bring BTL’s suite of devices to their franchises. “We are going into a multi-year purchasing agreement to onboard several hundred devices over that time period. We are working on launching our "EMsuite" within the iC
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Zubin Meshginpoosh Is Senté's New President and Chief Operating Officerhttps://modernaesthetics.com/news/zubin-meshginpoosh-is-sentes-new-president-and-chief-operating-officer/2473338/Zubin Meshginpoosh is now the President and Chief Operational Officer of Senté. "Zubin has an incredible track record for enabling teams to achieve success in high growth and fast-changing environments," says Faheem Hasnain, Chairman of the Board at Senté, in a n